Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
12.66
-0.57 (-4.31%)
At close: Aug 31, 2026, 4:00 PM EDT
12.60
-0.06 (-0.47%)
After-hours: Aug 31, 2026, 7:36 PM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $459.46 million as of August 31, 2026.
Market Cap
459.46M
Enterprise Value
267.29M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.66
ChartMarket Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has decreased from $481.24M to $459.46M, a decrease of -4.53%. That is a compound annual growth rate of -5.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 459.46M | -14.87% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 517.63M |
| Editas Medicine | 485.31M |
| Rezolute | 482.64M |
| Prothena Corporation | 478.97M |
| C4 Therapeutics | 473.65M |
| Vogenx | 472.64M |
| Ginkgo Bioworks Holdings | 468.69M |
| Puma Biotechnology | 467.68M |